IFNB1 and myeloid sarcoma: The mean of multiple sclerosis severity score (MSSS) and expanded disability status scale (EDSS)were measured to monitor the change in severity of MS in response to IFN-β therapy.Pearson’s Chi-square and analysis of variance (ANOVA) tests were the main statistical methods used in this study.